CHARLOTTESVILLE, Va. —LumaCyte, an advanced bioanalytical instrumentation leader for rapid label-free cellular analytics, today announced the closing of a B series financing that will further accelerate growth in the company’s automated bioproduction analytics solutions and expand its global infrastructure to meet growing demand. The financing was led by Malvern Panalytical, an international leader in advanced scientific […]

SAN DIEGO — Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has received a letter from the staff of the Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has regained compliance with Nasdaq’s minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing […]

Financing led by M Ventures, with participation from existing investors ARCH Venture Partners, Illumina Ventures, OMX Ventures, +ND Capital, and Longwall Ventures Novel single-cell platform allows users to control and profile massively parallel and sequential droplet- based assays, with end-to-end tracking and live cell recovery for downstream applications Funding will accelerate company growth and expansion […]

Novo Holdings, a leading international life science investor, today announced it has participated in a $290 million (USD) strategic financing round of Sangon Biotech. Sangon is a leading provider of life science tools and services, enabling scientists across China to perform state-of-the-art research in hospitals, universities and commercial settings. Based in China, and with close […]

SEOUL, SOUTH KOREA — Curiox Biosystems Inc., a global leader in providing innovative and automated sample preparation solutions for accurate and reproducible cell analysis, announced today the pricing of its initial public offering of 1,400,000 shares of its common stock at a price to the public of 13,000 won per share. Shares have started trading on the Korea […]

New financing will help scale manufacturing of BioFlyte’s novel biothreat surveillance solution to expand reach within aviation and mail screening applications ALBUQUERQUE, N.M. – BioFlyte, a biothreat detection firm with a revolutionary new class of fieldable biological threat collection, detection, and identification solutions, today announced that it raised $5.4M in new financing led by Scout Ventures and Cottonwood Technology Fund with […]

BEIJING — Recently, Atantares announced the completion of Pre-A and Pre-A+ financing all around RMB100 million. The Pre-A round is led by Asia Green Fund, followed by Fosun Health Capital and existing investors Frees Fund, Qiming Venture Partners, Next Capital, and NeuX Capital; Pre-A+ is exclusively invested by Alibaba Health. The fund will mainly go towards the R&D of […]

Next Gen RNA fragmentomics-based diagnostics SANTA CRUZ, CALIFORNIA, UNITED STATES — RealSeq Biosciences, Inc., a company developing RNA fragmentomics as real-time diagnostics for disease, today announced the close of its oversubscribed seed round. The investment allows RealSeq to deploy the RiboMarkerTM molecular diagnostics platform toward its first indication, Valley Fever, a fungal disease related to […]

Funding will be used to scale operations and continue development of its pioneering DNA synthesis platform, gSynth™ Funding round led by Mercia Camena has also strengthened the Board of Directors with key appointments Cambridge, UK: Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, today announced it has closed a $10m […]

Investment will help fuel international partnerships, grow IGX Platform functionality, and diversify proposition with new generative AI solutions Caption: The IGX Platform to select better antibodies. s-Hertogenbosch, The Netherlands — ENPICOM, an innovative bioinformatics software engineering company, has successfully secured further financial backing from its current investors BOP Capital, BOM Brabant Ventures, Nextgen Ventures, and […]